Regentis Biomaterials Ltd (RGNT) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2017 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Sep 30 2017 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Regentis Biomaterials Ltd   (RGNT)


Regentis Biomaterials Ltd 's ROA from the fourth quarter of 2025 to the fourth quarter of 2017 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Regentis Biomaterials Ltd 's ROA in the fourth quarter of 2025?
Regentis Biomaterials Ltd recorded a cumulative net loss of $-14 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -130.69%.

However, within the Healthcare sector 928 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 5159.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2017)
III. Quarter
Y / Y Total Assets Change 102.01 % 53.1 % 43.76 % 1063.28 % 1179.9 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -14 0 0 0 0
Return On Assets (TTM) -130.69 % -0.15 % -0.62 % -1.17 % -1.76 %
RGNT's Total Ranking # 5159 # # # #
Total Assets (TTM) in million 19 8 8 8 9
Seq. Total Assets Change 148.34 % 0 % 0 % -18.65 % 88.21 %
Seq. Net Income Change - - - - -

RGNT's 5 Years Annual ROA >> Back to RGNT Management Effectiveness >> Compare RGNT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 211
Sector # 929
Overall # 5112

Return On Assets Statistics
High Average Low
15.18 %
-45.46 %
-179.15 %
(Dec 31 2013)   (Dec 31 2025)





Financial Statements
Regentis Biomaterials Ltd 's Assets $ 19 million RGNT's Balance sheet
Regentis Biomaterials Ltd 's Income $ -14 million Quarterly RGNT's Income Statement
RGNT's Income by Division See RGNT's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2014)
FY 2014		 (Dec 31 2013)
FY 2013		 (Dec 31 2012)
FY 2012		 (Dec 31 2010)
FY 2011
Y / Y Total Assets Change 2461.51 % 10.1 % -7.44 % 3.31 % -
Total Assets in million 19 1 1 1 1
Y / Y Net Income Change - - - - -
Net Income in million -14 0 0 0 0
Annual Return On Assets -72.82 % -8.94 % 15.18 % -8.26 % 27.11 %

RGNT's 5 Years Annual ROA >> Back to RGNT Management Effectiveness >> Compare RGNT ROA to its Competitors



More Return On Assets Ratios
RGNT's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
RGNT's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for RGNT's Competitors
Subscribers only: Roa for Regentis Biomaterials Ltd 's Suppliers
Subscribers only: Return On Assets for RGNT's Customers

You may also want to know
RGNT's Roi RGNT's Inventory Turnover Ratio RGNT's Growth Rates RGNT's Dividend Comparisons
RGNT's Profitability Ratios RGNT's Asset Turnover Ratio RGNT's Dividend Growth
RGNT's Roe RGNT's Valuation Ratios RGNT's Financial Strength Ratios RGNT's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA

Date modified: 2026-07-07T13:05:50+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.